Rankings
▼
Calendar
TLSI Q2 2025 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q2 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$11M
+52.3% YoY
Gross Profit
$9M
83.9% margin
Operating Income
-$7M
-65.4% margin
Net Income
-$8M
-73.9% margin
EPS (Diluted)
$-0.27
QoQ Revenue Growth
+22.3%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$41M
Total Liabilities
$61M
Stockholders' Equity
-$19M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$7M
+52.3%
Gross Profit
$9M
$6M
+45.9%
Operating Income
-$7M
-$8M
+10.3%
Net Income
-$8M
-$4M
-91.3%
← FY 2025
All Quarters
Q3 2025 →